Press Email Subscription Year All Years 2019 2018 2017 2016 Keywords Go Advanced Search Search Search Headlines Only From To Mar 2, 2017 Medicenna Therapeutics Corp. (formerly A2 Acquisition Corp.) announces completion of qualifying transaction and related matters Jan 18, 2017 Medicenna Further Strengthens Management Team Jan 17, 2017 Medicenna Announces Additions to the Board of Directors Dec 15, 2016 Medicenna Strengthens Superkine Platform with Issuance of U.S. Patents Dec 13, 2016 Medicenna Announces Initiation of Phase 2 Clinical Trial of MDNA55 for the Treatment of Recurrent Glioblastoma Show 5102550100 per page«1…456789101112» Investor ContactFor more investor information, Please contact: Elizabeth Williams, Chief Financial Officer ir@medicenna.com Stock QuoteTSXMDNA Email Alerts * Required Fields * Email
